Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Daily News

African Americans’ Antiplatelet Response Handicapped by Gene Variant, ‘Race’

June 07, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

L.A. McKeown

May 23, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Daily News

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 09, 2012

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Daily News

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

Caitlin E. Cox

March 30, 2012

News Daily News

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Caitlin E. Cox

March 30, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

Advertisement

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

African Americans’ Antiplatelet Response Handicapped by Gene Variant, ‘Race’

Unknowns Predominate in Variable Clopidogrel Response

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content